8-K: Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
8-K: Current report
8-K: Current report
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | 8-K/A: Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
Barinthus Biotherapeutics | 8-K: Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | DEFA14A: Others
Barinthus Biotherapeutics | DEF 14A: Definitive information statements
Barinthus Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | 8-K: Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
Vaccitech | 8-K: Current report
Vaccitech | DEF 14A: Definitive information statements
Vaccitech | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Vaccitech | 8-K: Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
Vaccitech | 8-K: Current report
No Data